Search Results

Medtronic plc today announced that Karen Parkhill will resign as executive vice president and chief financial officer to accept the role of chief financial officer for HP Inc.

Arecor Therapeutics plc announced a research collaboration with Medtronic plc, a global leader in healthcare technology, to develop a novel, high concentration, thermostable insulin for use by Medtronic’s Diabetes business in a next-generation implantable pump.

Medtronic plc announced that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering of €850,000,000 principal amount of 3.650% senior notes due 2029, €850,000,000 principal amount of 3.875% senior notes due 2036, €600,000,000 principal amount of 4.150% senior notes due 2043, and €700,000,000 principal amount of 4.150% senior notes due 2053.

Medtronic plc announced that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering of €850,000,000 principal amount of 3.650% senior notes due 2029, €850,000,000 principal amount of 3.875% senior notes due 2036, €600,000,000 principal amount of 4.150% senior notes due 2043, and €700,000,000 principal amount of 4.150% senior notes due 2053.

The companies will work together to help save gastroenterologists time by providing real-time integration between ModMed’s gGastro® ASC and Medtronic’s GI Genius™.

Medtronic plc, a global leader in healthcare technology, announced it will participate in the 45th annual Goldman Sachs global healthcare conference on Tuesday, June 11, 2024.

Medtronic plc announced financial results for its fourth quarter and fiscal year 2024, which ended April 26, 2024.

Medtronic plc today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024.